Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 7 days ago

      After dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...

    • Why sinking colonoscopy pay is a growing threat

      Becker's ASC Review· 4 days ago

      Gastroenterologists across the country are facing low reimbursement rates for colonoscopy demand. George Dickstein, MD, vice president of clinical affairs of Gastro Health Massachusetts, joined ...

    • Gateway - Quartz

      Quartz· 6 days ago

      Inflation may have slowed down, but the price hikes of 2022 will be felt in next year’s insurance premiums, according to the latest analysis by Value Penguin, an insurance comparison site. The ...